EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ANTI-CD38 MONOCLONAL ANTIBODIES: TRANSFORMING MULTIPLE MYELOMA TREATMENT

Cem Selim

Hematology, Transfusion and Cell Therapy · 2024-12 · 46 · S14-S15

DOI: 10.1016/j.htct.2024.11.108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematology, Transfusion and Cell Therapy, 2024-12. Verfasst von Cem Selim. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Selim, C. (2024). ANTI-CD38 MONOCLONAL ANTIBODIES: TRANSFORMING MULTIPLE MYELOMA TREATMENT. Hematology, Transfusion and Cell Therapy, 46, S14-S15. https://doi.org/10.1016/j.htct.2024.11.108

Vancouver

Selim C. ANTI-CD38 MONOCLONAL ANTIBODIES: TRANSFORMING MULTIPLE MYELOMA TREATMENT. Hematology, Transfusion and Cell Therapy. 2024;46:S14-S15. doi:10.1016/j.htct.2024.11.108

BibTeX
@article{Selim2024,
  author = {Selim, Cem},
  title = {ANTI-CD38 MONOCLONAL ANTIBODIES: TRANSFORMING MULTIPLE MYELOMA TREATMENT},
  journal = {Hematology, Transfusion and Cell Therapy},
  year = {2024},
  volume = {46},
  pages = {S14--S15},
  doi = {10.1016/j.htct.2024.11.108}
}
Kostenlos starten →